• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿富汗喀布尔热疗治疗皮肤利什曼病的评估:一项随机对照试验。

Evaluation of thermotherapy for the treatment of cutaneous leishmaniasis in Kabul, Afghanistan: a randomized controlled trial.

作者信息

Safi Najibullah, Davis Gary D, Nadir Mohammed, Hamid Hamida, Robert Leon L, Case Alan J

机构信息

Primary Health Care Department, World Health Organization Country Office, UNOCA Compound, Jalalabad Road, Kabul, Islamic Republic of Afghanistan.

出版信息

Mil Med. 2012 Mar;177(3):345-51. doi: 10.7205/milmed-d-11-00161.

DOI:10.7205/milmed-d-11-00161
PMID:22479925
Abstract

Anthroponotic cutaneous leishmaniasis (CL) is a common cause of ulcerative lesions and disfiguring scarring among children in Afghanistan. Most lesions occur on the face and are commonly caused by the trypanosome protozoan parasite Leishmania tropica, transmitted by the bite of an infected sandfly (Phlebotomus sergenti). This study compared the effectiveness of a single localized treatment with thermotherapy to 5 days of intralesional administration of Glucantime for the treatment of CL. Three hundred and eighty-two patients with CL were randomly assigned to the two treatment groups and followed for 6 months. The cure rate for the thermotherapy group was 82.5%, compared to 74% in the Glucantime group. The authors concluded that a single localized treatment with thermotherapy was more effective than 5 days of intralesional administration of Glucantime. Additionally, thermotherapy was more cost-effective, with fewer side effects, of shorter duration, and with better patient compliance than intralesional Glucantime.

摘要

人源性皮肤利什曼病(CL)是阿富汗儿童溃疡性病变和毁容性瘢痕的常见病因。大多数病变发生在面部,通常由热带利什曼原虫这种锥虫原生动物寄生虫引起,通过受感染白蛉( Sergenti 白蛉)叮咬传播。本研究比较了热疗单一局部治疗与5天病灶内注射葡糖胺锑钠治疗CL的效果。382例CL患者被随机分配到两个治疗组,并随访6个月。热疗组的治愈率为82.5%,而葡糖胺锑钠组为74%。作者得出结论,热疗单一局部治疗比5天病灶内注射葡糖胺锑钠更有效。此外,与病灶内注射葡糖胺锑钠相比,热疗更具成本效益,副作用更少,疗程更短,患者依从性更好。

相似文献

1
Evaluation of thermotherapy for the treatment of cutaneous leishmaniasis in Kabul, Afghanistan: a randomized controlled trial.阿富汗喀布尔热疗治疗皮肤利什曼病的评估:一项随机对照试验。
Mil Med. 2012 Mar;177(3):345-51. doi: 10.7205/milmed-d-11-00161.
2
Comparative study of the efficacy of combined cryotherapy and intralesional meglumine antimoniate (Glucantime) vs. cryotherapy and intralesional meglumine antimoniate (Glucantime) alone for the treatment of cutaneous leishmaniasis.联合冷冻疗法与病灶内注射葡甲胺锑酸盐(葡酸锑钠)对比单独使用冷冻疗法和病灶内注射葡甲胺锑酸盐(葡酸锑钠)治疗皮肤利什曼病的疗效比较研究
Int J Dermatol. 2004 Apr;43(4):281-3. doi: 10.1111/j.1365-4632.2004.02002.x.
3
Efficacy of CO(2) laser for treatment of anthroponotic cutaneous leishmaniasis, compared with combination of cryotherapy and intralesional meglumine antimoniate.二氧化碳激光治疗人体皮肤利什曼病的疗效,与冷冻疗法和病灶内注射葡甲胺锑治疗的联合疗法相比。
J Eur Acad Dermatol Venereol. 2011 May;25(5):587-91. doi: 10.1111/j.1468-3083.2010.03781.x.
4
Thermotherapy. An alternative for the treatment of American cutaneous leishmaniasis.热疗。一种治疗美国皮肤利什曼病的替代方法。
Trials. 2012 May 17;13:58. doi: 10.1186/1745-6215-13-58.
5
Efficacy of glucantime for treatment of cutaneous leishmaniasis in Central Iran.葡萄糖酸锑钠治疗伊朗中部皮肤利什曼病的疗效。
J Infect Public Health. 2013 Apr;6(2):120-4. doi: 10.1016/j.jiph.2012.11.003. Epub 2013 Feb 1.
6
Efficacy of cryotherapy versus intralesional meglumine antimoniate (glucantime) for treatment of cutaneous leishmaniasis in children.冷冻疗法与病灶内注射葡甲胺锑酸盐(葡糖胺锑)治疗儿童皮肤利什曼病的疗效比较
Am J Trop Med Hyg. 2009 Feb;80(2):172-5.
7
Comparison of intralesional meglumine antimoniate, cryotherapy and their combination in the treatment of cutaneous leishmaniasis.病灶内注射葡甲胺锑酸盐、冷冻疗法及其联合应用治疗皮肤利什曼病的比较。
Int J Dermatol. 2006 Sep;45(9):1115-6. doi: 10.1111/j.1365-4632.2006.02822.x.
8
Comparison of Intralesional Sodium Stibogluconate versus Intralesional Meglumine Antimoniate for the Treatment of Leishmania major Cutaneous Leishmaniasis.比较葡萄糖酸锑钠与喷他脒治疗皮肤利什曼病。
Acta Derm Venereol. 2024 Apr 29;104:adv35089. doi: 10.2340/actadv.v104.35089.
9
Comparing the efficiency of topical paromomycin with intralesional meglumine antimoniate for cutaneous leishmaniasis.比较局部用巴龙霉素与病灶内注射葡甲胺锑酸盐治疗皮肤利什曼病的疗效。
Int J Dermatol. 2005 Dec;44(12):1064-5. doi: 10.1111/j.1365-4632.2004.02597.x.
10
Comparative study of the efficacy of oral ketoconazole with intra-lesional meglumine antimoniate (Glucantime) for the treatment of cutaneous leishmaniasis.口服酮康唑与病灶内注射葡甲胺锑酸盐(葡醛锑钠)治疗皮肤利什曼病的疗效比较研究。
J Dermatolog Treat. 2001 Sep;12(3):159-62. doi: 10.1080/09546630152607899.

引用本文的文献

1
Cutaneous leishmaniasis in Afghanistan.阿富汗的皮肤利什曼病
Trans R Soc Trop Med Hyg. 2025 Aug 8;119(8):848-864. doi: 10.1093/trstmh/traf028.
2
Impetiginous Cutaneous Leishmaniasis after COVID-19 Infection in a Patient with Poor Cardiac Profile: A Case Report and Literature Review.心脏功能不佳患者新冠病毒感染后发生脓疱性皮肤利什曼病:病例报告及文献综述
Trop Med Infect Dis. 2023 Sep 10;8(9):443. doi: 10.3390/tropicalmed8090443.
3
Effectiveness of intralesional sodium stibogluconate for the treatment of localized cutaneous leishmaniasis at Boru Meda general hospital, Amhara, Ethiopia: Pragmatic trial.
在埃塞俄比亚阿姆哈拉邦 Boru Meda 综合医院,局部皮肤利什曼病采用博来霉素治疗的疗效:实用临床试验。
PLoS Negl Trop Dis. 2022 Sep 9;16(9):e0010578. doi: 10.1371/journal.pntd.0010578. eCollection 2022 Sep.
4
Health Status of Afghan Refugees in Europe: Policy and Practice Implications for an Optimised Healthcare.欧洲阿富汗难民的健康状况:优化医疗保健的政策和实践意义。
Int J Environ Res Public Health. 2022 Jul 27;19(15):9157. doi: 10.3390/ijerph19159157.
5
Treatment of Cutaneous Leishmaniasis and Insights into Species-Specific Responses: A Narrative Review.皮肤利什曼病的治疗及物种特异性反应的见解:一篇叙述性综述
Infect Dis Ther. 2022 Apr;11(2):695-711. doi: 10.1007/s40121-022-00602-2. Epub 2022 Feb 22.
6
Heat therapy for cutaneous leishmaniasis: A literature Review.皮肤利什曼病的热疗法:文献综述
J Res Med Sci. 2021 Feb 27;26:15. doi: 10.4103/jrms.JRMS_934_19. eCollection 2021.
7
Effectiveness of miltefosine in cutaneous leishmaniasis caused by Leishmania tropica in Pakistan after antimonial treatment failure or contraindications to first line therapy-A retrospective analysis.米替福新治疗巴基斯坦利什曼原虫引起的皮肤利什曼病(锑剂治疗失败或一线治疗禁忌后)的疗效:回顾性分析。
PLoS Negl Trop Dis. 2021 Jan 28;15(1):e0008988. doi: 10.1371/journal.pntd.0008988. eCollection 2021 Jan.
8
Failure of an Innovative Low-Cost, Noninvasive Thermotherapy Device for Treating Cutaneous Leishmaniasis Caused by in Pakistan.一种创新的低成本、非侵入性热疗设备治疗巴基斯坦感染引起的皮肤利什曼病失败。
Am J Trop Med Hyg. 2019 Dec;101(6):1373-1379. doi: 10.4269/ajtmh.19-0430.
9
Exploiting knowledge on pharmacodynamics-pharmacokinetics for accelerated anti-leishmanial drug discovery/development.利用药效动力学-药代动力学知识加速抗利什曼病药物的发现/开发。
Expert Opin Drug Metab Toxicol. 2019 Jul;15(7):595-612. doi: 10.1080/17425255.2019.1629417. Epub 2019 Jun 17.
10
A Functional Wound Dressing as a Potential Treatment for Cutaneous Leishmaniasis.一种功能性伤口敷料作为皮肤利什曼病的潜在治疗方法。
Pharmaceutics. 2019 May 1;11(5):200. doi: 10.3390/pharmaceutics11050200.